Dyne Therapeutics 40% Rally Faces Fund Selloff Questions
A dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Understand what benefits points can get you on a credit card. Discover the rewards and perks waiting for you.
22,891 articlesA dramatic 40% jump for Dyne Therapeutics has investors watching closely as a biotech-focused fund disclosed a sizabl...
Late-career savers confront a hard truth: retirement funding offers fewer options than college savings. Experts say c...
Groupon is charting a new path in local commerce as 2025 earnings loom. This guide breaks down the drivers, risks, an...
Investors rotated into defensive names, helping Molina Healthcare stock cruised to near-a-10% weekly gain. Learn what...
Alphabet raising $84.75 billion marks a bold turn in how tech giants fund AI bets. This article breaks down what it c...
A new NVIDIA-backed player has stepped into the high-growth AI photonics space, challenging traditional data-center b...
The crypto world pivoted last week as a regulator-approved platform hit a $1 billion weekly volume in perpetual futur...
As 2026 unfolds, investors eye three key covered call ETFs for steady monthly income. This analysis compares ISPY, JE...
CubeSmart sits in a crowded self-storage field. This guide breaks down the key indicators I watch to assess whether C...
A high-profile disappearance draws volunteers and financial strain alike. This article breaks down the money moves fa...
A thoughtful look at Xeris Biopharma's Q4 2025 earnings, the company’s pipeline milestones, and what xeris biopharma ...
Kohl's stock moved in dramatic strides after its latest earnings report, tumbling early before a sharp rally. This ar...